BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 33677881)

  • 1. [Clinicopathological features of inflammatory myofibroblastic tumor].
    Zhu Y; Ding Y; Song GX; Li X; Ding R; Fan QH; Gong QX
    Zhonghua Bing Li Xue Za Zhi; 2021 Mar; 50(3):194-200. PubMed ID: 33677881
    [No Abstract]   [Full Text] [Related]  

  • 2. Epithelioid inflammatory myofibroblastic sarcoma: a clinicopathological, immunohistochemical and molecular cytogenetic analysis of five additional cases and review of the literature.
    Yu L; Liu J; Lao IW; Luo Z; Wang J
    Diagn Pathol; 2016 Jul; 11(1):67. PubMed ID: 27460384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK.
    Mariño-Enríquez A; Wang WL; Roy A; Lopez-Terrada D; Lazar AJ; Fletcher CD; Coffin CM; Hornick JL
    Am J Surg Pathol; 2011 Jan; 35(1):135-44. PubMed ID: 21164297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine Inflammatory Myofibroblastic Neoplasms With Aggressive Behavior, Including an Epithelioid Inflammatory Myofibroblastic Sarcoma: A Clinicopathologic Study of 9 Cases.
    Collins K; Ramalingam P; Euscher ED; Reques Llanos A; García A; Malpica A
    Am J Surg Pathol; 2022 Jan; 46(1):105-117. PubMed ID: 34138797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinicopathologic features of extrapulmonary inflammatory myofibroblastic tumor].
    Li H; Shen Q; Xia Q; Shi S; Zhang R; Yu B; Ma H; Lu Z; Wang X; He Y; Zhou X; Rao Q
    Zhonghua Bing Li Xue Za Zhi; 2014 Jun; 43(6):370-4. PubMed ID: 25208985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory myofibroblastic tumor and low-grade myofibroblastic sarcoma: a comparative study of clinicopathologic features and further observations on the immunohistochemical profile of myofibroblasts.
    Qiu X; Montgomery E; Sun B
    Hum Pathol; 2008 Jun; 39(6):846-56. PubMed ID: 18400254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of EML4-ALK as an alternative fusion gene in epithelioid inflammatory myofibroblastic sarcoma.
    Jiang Q; Tong HX; Hou YY; Zhang Y; Li JL; Zhou YH; Xu J; Wang JY; Lu WQ
    Orphanet J Rare Dis; 2017 May; 12(1):97. PubMed ID: 28535796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma.
    Montgomery EA; Shuster DD; Burkart AL; Esteban JM; Sgrignoli A; Elwood L; Vaughn DJ; Griffin CA; Epstein JI
    Am J Surg Pathol; 2006 Dec; 30(12):1502-12. PubMed ID: 17122505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inflammatory myofibroblastic tumors of the urinary bladder: a clinicopathological study of ten cases].
    Zhang HZ; Wang SY; Dong L; Yang XQ; Wang CF
    Zhonghua Bing Li Xue Za Zhi; 2021 Sep; 50(9):1024-1028. PubMed ID: 34496493
    [No Abstract]   [Full Text] [Related]  

  • 10. Inflammatory myofibroblastic tumor arising from soft tissues of extremities harboring a novel CLIP2-ALK fusion.
    Ding R; Li X; Zhu XM; Song QX; Fan QH; Zhang ZH; Gong QX
    Pathol Int; 2020 Oct; 70(10):798-803. PubMed ID: 32716129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abdominal inflammatory myofibroblastic tumour: Clinicopathological and molecular analysis of 20 cases, highlighting potential therapeutic targets.
    Vernemmen AIP; Samarska IV; Speel EM; Riedl RG; Goudkade D; de Bruïne AP; Wouda S; van Marion AM; Verlinden IV; van Lijnschoten I; Friederich P; Winnepenninckx VJL; Zur Hausen A; Sciot RME; van den Hout MFCM
    Histopathology; 2024 Apr; 84(5):794-809. PubMed ID: 38155480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dedifferentiated liposarcoma with inflammatory myofibroblastic tumor-like features: a clinicopathological analysis of five cases].
    Si HP; Wang Z; Fan QH; Zhang YF; Yang DQ; Zhang ZH; Gong QX
    Zhonghua Bing Li Xue Za Zhi; 2019 Apr; 48(4):282-287. PubMed ID: 30955263
    [No Abstract]   [Full Text] [Related]  

  • 13. Pulmonary epithelioid inflammatory myofibroblastic sarcoma with multiple bone metastases: case report and review of literature.
    Fu X; Jiang J; Tian XY; Li Z
    Diagn Pathol; 2015 Jul; 10():106. PubMed ID: 26178751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uterine Inflammatory Myofibroblastic Tumor Showing an Atypical ALK Signal Pattern by FISH and DES-ALK Fusion by RNA Sequencing: A Case Report.
    Zarei S; Abdul-Karim FW; Chase DM; Astbury C; Policarpio-Nicolas MLC
    Int J Gynecol Pathol; 2020 Mar; 39(2):152-156. PubMed ID: 30741845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding the Molecular Characterization of Thoracic Inflammatory Myofibroblastic Tumors beyond ALK Gene Rearrangements.
    Chang JC; Zhang L; Drilon AE; Chi P; Alaggio R; Borsu L; Benayed R; Travis WD; Ladanyi M; Antonescu CR
    J Thorac Oncol; 2019 May; 14(5):825-834. PubMed ID: 30550870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALK Immunoexpression is Specific for Inflammatory Myofibroblastic Tumor Among Vulvovaginal Mesenchymal Neoplasms.
    Bowman CJ; Medeiros F; Fadare O; Sangoi AR; Horvai AE; Devine WP; McCluggage WG; Rabban JT
    Int J Gynecol Pathol; 2023 Jan; 42(1):1-10. PubMed ID: 35180768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological analysis of epithelioid inflammatory myofibroblastic sarcoma.
    Du X; Gao Y; Zhao H; Li B; Xue W; Wang D
    Oncol Lett; 2018 Jun; 15(6):9317-9326. PubMed ID: 29805657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Durable Clinical Response to ALK Tyrosine Kinase Inhibitors in Epithelioid Inflammatory Myofibroblastic Sarcoma Harboring
    Wang Z; Geng Y; Yuan LY; Wang MM; Ye CY; Sun L; Dai WP; Zang YS
    Front Oncol; 2022; 12():761558. PubMed ID: 35237506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytopathologic features of epithelioid inflammatory myofibroblastic sarcoma with correlation of histopathology, immunohistochemistry, and molecular cytogenetic analysis.
    Lee JC; Wu JM; Liau JY; Huang HY; Lo CY; Jan IS; Hornick JL; Qian X
    Cancer Cytopathol; 2015 Aug; 123(8):495-504. PubMed ID: 26139079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinicopathologic features and immunophenotype of pseudosarcomatous myofibroblastic proliferation of urinary bladder].
    Zhang YH; Zhang XR; Yu J; Li HL
    Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):585-590. PubMed ID: 30107662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.